NEURORESTORE

Welcome to the Brand page for “NEURORESTORE”, which is offered here for Development of pharmaceutical substances for treatment and easement of alzheimer's disease, only for human use; scientific and technological services, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical drug development services, pharmaceutical product evaluation and pharmaceutical research and development; scientific research and design, scientific research in the field of pharmaceuticals; research in relation to pharmaceuticals; research and development of vaccines and medicines; conducting early stage evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; drug discovery services; technical data analysis services, data analysis through data mining; computer-supported technical analysis services, chemical analysis, and data analysis through data mining;.

Its status is currently believed to be active. Its class is unavailable. “NEURORESTORE” is believed to be currently owned by “AlzeCure Pharma AB”.


Owner:
ALZECURE PHARMA AB
Owner Details
Description:
Development of pharmaceutical substances for treatment and easement of Alzheimer's disease, only for human use; Scientific and technological services, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical drug development services, pharmaceutical product evaluation and pharmaceutical research and development; scientific research and design, scientific research in the field of pharmaceuticals; Research in relation to pharmaceuticals; Research and development of vaccines and medicines; Conducting early stage evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Drug discovery services; Technical data analysis services, data analysis through data mining; Computer-supported technical analysis services, chemical analysis, and data analysis through data mining;
Categories: DEVELOPMENT PHARMACEUTICAL SUBSTANCES